SCHEMBL23017008

SCHEMBL23017008

Cn1c2ccccc2c2ccc(-n3c4ccccc4c4ccccc43)c(-c3c(-n4c5ccccc5c5ccccc54)ccc4c5ccccc5n(C)c34)c21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.54
IDO1 P14902 1/20 0.54
ALKBH5 Q6P6C2 1/20 0.53
FTO Q9C0B1 1/20 0.53
GPR3 P46089 1/20 0.52
KDM4E B2RXH2 7/20 0.44
ALDH1A1 P00352 5/20 0.44
HSD17B10 Q99714 4/20 0.44
HPGD P15428 4/20 0.44
GLA P06280 2/20 0.44
GAA P10253 2/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 3/20 0.43
KIF11 P52732 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
ATM Q13315 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
LIMK1 P53667 1/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23373480 0.81 ALKBH5 (0.61) HSP90AA1IDO1ALKBH5FTOGPR3
SCHEMBL13564071 0.80 GPR3 (0.71) HSP90AA1IDO1ALKBH5FTOGPR3
SCHEMBL3423943 0.80 GPR3 (0.71) HSP90AA1IDO1ALKBH5FTOGPR3
SCHEMBL23373406 0.80 ALKBH5 (0.59) HSP90AA1IDO1ALKBH5FTOGPR3
SCHEMBL23017013 0.79 L3MBTL1 (0.59) HSP90AA1IDO1KDM4EALDH1A1HPGD
SCHEMBL23017011 0.78 PGR (0.51) KDM4EALDH1A1HSD17B10HPGDLMNA
SCHEMBL23373434 0.76 ALKBH5 (0.53) HSP90AA1IDO1ALKBH5FTOGPR3
SCHEMBL10206053 0.75 KDM4E (0.59) HSP90AA1IDO1ALKBH5FTOGPR3
SCHEMBL18416278 0.75 KDM4E (0.59) HSP90AA1IDO1ALKBH5FTOGPR3
SCHEMBL22906562 0.75 ALKBH5 (0.53) HSP90AA1IDO1ALKBH5FTOGPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3782984-B1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO LTD (KR) 2023-04-05 EP disclosed
US-20210057652-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-02-25 US disclosed
EP-3782984-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE Samsung Display Co., Ltd. (KR) 2021-02-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210057652-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE NUCB2, NCL, NES HSP90AA1 4650/4885IDO1 1682/4885ALKBH5 1376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.